Cell cycle progression score improves risk stratification in prostate cancer patients with adverse pathology after radical prostatectomy

ConclusionsThe present study provides insights into the role the CCP score plays in risk stratification of this cohort and in determining candidacy for deferred secondary treatment. From our perspective, the CCP score allows better stratification and can help identifying patients at lower risk of disease recurrence who could benefit from a wait-and-see policy.

Source: Journal of Cancer Research and Clinical Oncology - February 25, 2020 Category: Cancer & Oncology Source Type: research